Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,042,819
-
Share change
-
+2,568,233
-
Total reported value
-
$42,040,702
-
Put/Call ratio
-
66%
-
Price per share
-
$4.65
-
Number of holders
-
57
-
Value change
-
+$12,361,283
-
Number of buys
-
31
-
Number of sells
-
19
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q1 2021
As of 31 Mar 2021,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,042,819 shares.
The largest 10 holders included
ETF MANAGERS GROUP, LLC, AdvisorShares Investments LLC, VANGUARD GROUP INC, Davy Global Fund Management Ltd, BlackRock Inc., Penserra Capital Management LLC, D. E. Shaw & Co., Inc., Mirae Asset Global Investments Co., Ltd., GEODE CAPITAL MANAGEMENT, LLC, and CITADEL ADVISORS LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.